London
){kind=logo}
With a commitment to integrity, partnership and reliability, ALTURiX has a growing portfolio of high-quality, responsibly-priced medicines that improve patient outcomes while ensuring cost effectiveness for healthcare providers. Our portfolio includes seven branded medicines across central nervous system, respiratory disease and endocrinology. Our products are designed to enhance patient health while delivering value to healthcare providers. ALTURiX is set to expand further with two additional products launching in the next 12 months.
In 2025, ALTURiX became part of Kelso Pharma, a specialty pharmaceutical company that shares our commitment to delivering innovative, cost-effective treatments.
Address
287 Upper FourthMilton Keynes
Bucks
MK9 1EH
United Kingdom
